Deals in Depth: July 2010

Article preview from In-Vivo - July, 2010

Alliance leaders included GSK's €73.9 million investment in new partner Dong-A Pharmaceutical and Medtronic's $70 million investment in cardiovascular device company BioControl. Abbott led biopharma M&A; activity with its $3.7 billion purchase of Piramal's healthcare solutions business. In devices, Endo paid $221 million up front for HealthTronics. Roughly 30 percent of the month's $953 million in biopharma fundraising came from Salix's $291 million debt deal. No public device dollars were realized in May, though 11 companies completed venture rounds.

Deals in Depth: July 2010

Our monthly overview of dealmaking in the biopharmaceutical, medical device and in vitro diagnostics industries.

by Beth Detuzzi

May 2010 dealmaking highlights:

Alliance leaders included GSK's €73.9 million equity investment in new co-promotion partner Dong-A Pharmaceutical and Medtronic's $70 million investment in cardiovascular device company BioControl. Sanofi also spent about $70 million in total up-front money through two deals with Nichi-Iko and Glenmark.

Abbott led biopharma M&A; activity with its $3.7 billion purchase of Piramal's healthcare solutions business. In devices, we saw Endo pay $221 million up front for HealthTronics, while CR Bard put up $193 million for breast cancer device company SenoRx.

Roughly 30 percent of the month's $953 million in biopharma fundraising came from Salix's $291 million debt deal. No public device dollars were realized in May, though 11 companies completed venture rounds, up from eight in April.

Click image to view full size

Click image to view full size

Click image to view full size

Click image to view full size

Click image to view full size

Elsevier Business Intelligence announces the publication of a new Special Report "Bigger, Tougher,Faster"- Preparing for the New FDA. When the inspector comes calling ... will you be ready? This 16-page report originally published in "The Silver Sheet". Learn more... 

Limited-time offer: Single-incision laparoscopy or natural orifice surgery: Which will win the day, or is there room for both? Are You Ready For The New Scarless Surgery Revolution? Download your FREE report now!

Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512